Skip to main content
. 2019 Jun;11(6):2287–2296. doi: 10.21037/jtd.2019.06.05

Figure 2.

Figure 2

Comparison of the BAL differential cell counts between, sarcoidosis patients with/without Löfgren’s syndrome (CXR stage 1), sarcoidosis patients with CXR =2, sarcoidosis patients with advanced disease stage (CXR stage 3) and other interstitial lung diseases. *, Pc<0.05; **, Pc<0.01; ***, Pc<0.001; ****, Pc<0.0001. BAL, bronchoalveolar lavage; S, sarcoidosis; LS, Löfgren’s syndrome; CXR, chest X-ray; IPF, idiopathic pulmonary fibrosis; OIIPs, other idiopathic interstitial pneumonias; HP, hypersensitivity pneumonitis.